Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 38001 - 38025 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Entinostat	Investigational	NRG1	3084	downregulated	entinostat results in decreased expression of NRG1 mRNA	8p12	A21037
Entinostat	Investigational	NRGN	4900	upregulated	entinostat results in increased expression of NRGN mRNA	11q24.2	A21035
Entinostat	Investigational	NRIP3	56675	downregulated	entinostat results in decreased expression of NRIP3 mRNA	11p15.4	A21037
Entinostat	Investigational	NRIP3	56675	upregulated	entinostat results in increased expression of NRIP3 mRNA	11p15.4	A21035
Entinostat	Investigational	NRK	203447	upregulated	entinostat results in increased expression of NRK mRNA	Xq22.3	A21037
Entinostat	Investigational	NRN1	51299	downregulated	entinostat results in decreased expression of NRN1 mRNA	6p25.1	A21035
Entinostat	Investigational	NRP1	8829	upregulated	entinostat results in increased expression of NRP1 mRNA	10p11.22	A21037
Entinostat	Investigational	NRP2	8828	upregulated	entinostat results in increased expression of NRP2 mRNA	2q33.3	A21037
Entinostat	Investigational	NRTN	4902	upregulated	entinostat results in increased expression of NRTN mRNA	19p13.3	A21035
Entinostat	Investigational	NSD2	7468	downregulated	entinostat results in decreased expression of NSD2 mRNA	4p16.3	A21037
Entinostat	Investigational	NSMAF	8439	downregulated	entinostat results in decreased expression of NSMAF mRNA	8q12.1	A21035
Entinostat	Investigational	NSUN7	79730	upregulated	entinostat results in increased expression of NSUN7 mRNA	4p14	A21035
Entinostat	Investigational	NTF4	4909	upregulated	entinostat results in increased expression of NTF4 mRNA	19q13.3	A21037
Entinostat	Investigational	NTN4	59277	downregulated	entinostat results in decreased expression of NTN4 mRNA	12q22	A21037
Entinostat	Investigational	NTRK2	4915	downregulated	entinostat results in decreased expression of NTRK2 mRNA	9q21.33	A21035
Entinostat	Investigational	NUCB2	4925	downregulated	entinostat results in decreased expression of NUCB2 mRNA	11p15.1	A21037
Entinostat	Investigational	NWD2	57495	upregulated	entinostat results in increased expression of NWD2 mRNA	4p14	A21037
Entinostat	Investigational	NXPE3	91775	upregulated	entinostat results in increased expression of NXPE3 mRNA	3q12.3	A21035
Entinostat	Investigational	OAT	4942	upregulated	entinostat results in increased expression of OAT mRNA	10q26.13	A21037
Entinostat	Investigational	OBSL1	23363	upregulated	entinostat results in increased expression of OBSL1 mRNA	2q35	A21035
Entinostat	Investigational	ODF3B	440836	upregulated	entinostat results in increased expression of ODF3B mRNA	22q13.33	A21035
Entinostat	Investigational	OGDHL	55753	upregulated	entinostat results in increased expression of OGDHL mRNA	10q11.23	A21037
Entinostat	Investigational	OGFOD1	55239	downregulated	entinostat results in decreased expression of OGFOD1 mRNA	16q13	A21037
Entinostat	Investigational	OGG1	4968	downregulated	entinostat results in decreased expression of OGG1 mRNA	3p25.3	A21037
Entinostat	Investigational	OGT	8473	downregulated	entinostat results in decreased expression of OGT mRNA	Xq13.1	A21035

Displaying entries 38001 - 38025 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability